Baltic and Eurasia Masterclass in Clinical Oncology
Ovarian Cancer Treatments: Role of 1st Line Bevacizumab, Maintenance Olaparib and Single Agent Immune Checkpoint Inhibitors in Advanced Setting
Comments 0
Login to view comments.
Click here to Login